PaulWilliamSmithMD

Psychiatry • Jamaica, NY

Physician

Join to view full profile

Are you Dr. Smith?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 31 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
8268 164th St
Jamaica, NY 11432
Phone+1 718-883-3225

Fax+1 718-883-6193
Is this information wrong?

Summary

Dr. Paul Smith, MD is a psychiatrist in Jamaica, New York. He is currently licensed to practice medicine in New York.

Education & Training

Newark Beth Israel Medical CenterFellowship, Clinical Pharmacology, 1987 - 1989
Stony Brook Medicine/University Hospital Public Health and General Preventive MedicineResidency, Public Health and General Preventive Medicine, 1986 - 1987
Icahn School of Medicine at Mount Sinai (NYC Health and Hospitals/Elmhurst)Residency, Internal Medicine, 1983 - 1986
University of the West Indies Faculty of Medical SciencesClass of 1979

Certifications & Licensure

NY State Medical License 1995 - 2016

Publications & Presentations

PubMed

Discovery of N-[(2S)-5-(6-fluoro-3-pyridinyl)-2,3-dihydro-1H-inden-2-yl]-2-propanesulfonamide, a novel clinical AMPA receptor positive modulator.
Ward, S.E., Harries, M., Aldegheri, L., Andreotti, D., Ballantine, S., Bax, B.D., Harris, A.J., Harker, A.J., Lund, J., Melarange, R., Mingardi, A., Mookherjee, C., Mo...> ;J Med Chem. 2010 Aug 12
Discovery of potent, orally bioavailable, selective 5-HT1A/B/D receptor antagonists.
Ward, S.E., Eddershaw, P.J., Scott, C.M., Gordon, L.J., Lovell, P.J., Moore, S.H., Smith, P.W., Starr, K.R., Thewlis, K.M., Watson, J.M.> ;J Med Chem. 2008 May 22
Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes ...
Taylor, N. R., Cleasby, A., Singh, O., Skarzynski, T., Wonacott, A. J., Smith, P. W., Sollis, S. L., Howes, P. D., Cherry, P. C., Bethell, R., Colman, P., Varghese, J.> ;J Med Chem. 1998 Mar 12
Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 1. Discovery, synthesis, biological activity, and structure-ac...
Smith, P. W., Sollis, S. L., Howes, P. D., Cherry, P. C., Starkey, I. D., Cobley, K. N., Weston, H., Scicinski, J., Merritt, A., Whittington, A., Wyatt, P., Taylor, N....> ;J Med Chem. 1998 Mar 12
Therapeutic utility of NK3 receptor antagonists for the treatment of schizophrenia.
Dawson, L. A., Smith, P. W.> ;Curr Pharm Des. 2010 Jan
Neurokinin 3 (NK3) receptor modulators for the treatment of psychiatric disorders.
Smith, P. W., Dawson, L. A.> ;Recent Pat CNS Drug Discov. 2008 Jan
New spiropiperidines as potent and selective non-peptide tachykinin NK2 receptor antagonists.
Smith, P. W., Cooper, A. W., Bell, R., Beresford, I. J., Gore, P. M., McElroy, A. B., Pritchard, J. M., Saez, V., Taylor, N. R., Sheldrick, R. L.> ;J Med Chem. 1995 Sep 15
The identification of structurally novel, selective, orally bioavailable positive modulators of mGluR2.
D'Alessandro, P. L., Corti, C., Roth, A., Ugolini, A., Sava, A., Montanari, D., Bianchi, F., Garland, S. L., Powney, B., Koppe, E. L., Rocheville, M., Osborne, G., Per...> ;Bioorg Med Chem Lett. 2010 Jan 15
3,4-Dihydro-2H-benzoxazinones as dual-acting 5-HT1A receptor antagonists and serotonin reuptake inhibitors.
Lovell, P. J., Blaney, F. E., Goodacre, C. J., Scott, C. M., Smith, P. W., Starr, K. R., Thewlis, K. M., Vong, A. K., Ward, S. E., Watson, J. M.> ;Bioorg Med Chem Lett. 2007 Feb 15
Studies on a series of potent, orally bioavailable, 5-HT(1) receptor ligands--part II.
Ward, S. E., Eddershaw, P., Flynn, S. T., Gordon, L., Lovell, P. J., Moore, S. H., Scott, C. M., Smith, P. W., Thewlis, K. M., Wyman, P. A.> ;Bioorg Med Chem Lett. 2009 Jan 15
In vitro and in vivo comparison of two non-peptide tachykinin NK3 receptor antagonists: Improvements in efficacy achieved through enhanced brain penetration or altered...
Dawson, L. A., Langmead, C. J., Dada, A., Watson, J. M., Wu, Z., de la Flor, R., Jones, G. A., Cluderay, J. E., Southam, E., Murkitt, G. S., Hill, M. D., Jones, D. N.,...> ;Eur J Pharmacol. 2010 Feb 10
Studies on a series of potent, orally bioavailable, 5-HT(1) receptor ligands.
Ward, S. E., Johnson, C. N., Lovell, P. J., Scott, C. M., Smith, P. W., Stemp, G., Thewlis, K. M., Vong, A. K., Watson, J. M.> ;Bioorg Med Chem Lett. 2007 Sep 15
The discovery of a series of N-substituted 3-(4-piperidinyl)-1,3-benzoxazolinones and oxindoles as highly brain penetrant, selective muscarinic M1 agonists.
Johnson, D. J., Forbes, I. T., Watson, S. P., Garzya, V., Stevenson, G. I., Walker, G. R., Mudhar, H. S., Flynn, S. T., Wyman, P. A., Smith, P. W., Murkitt, G. S., Luc...> ;Bioorg Med Chem Lett. 2010 Sep 15
New quinoline NK3 receptor antagonists with CNS activity.
Smith, P. W., Wyman, P. A., Lovell, P., Goodacre, C., Serafinowska, H. T., Vong, A., Harrington, F., Flynn, S., Bradley, D. M., Porter, R., Coggon, S., Murkitt, G., Se...> ;Bioorg Med Chem Lett. 2009 Feb 01
Identification of a potent and selective 5-HT1B receptor antagonist.
Wyman, P. A., Marshall, H. R., Flynn, S. T., King, R. J., Thompson, M., Smith, P. W., Hadley, M. S., Price, G. W., Scott, C. M., Dawson, L. A.> ;Bioorg Med Chem Lett. 2005 Nov 1
Novel 5-HT(1A/1B/1D) receptors antagonists with potent 5-HT reuptake inhibitory activity.
Serafinowska, H. T., Blaney, F. E., Lovell, P. J., Merlo, G. G., Scott, C. M., Smith, P. W., Starr, K. R., Watson, J. M.> ;Bioorg Med Chem Lett. 2008 Oct 15
SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2''methyl-4''-(5-methyl-1,2,3-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochlori...
Scott, C., Langmead, C. J., Clarke, K. L., Wyman, P., Smith, P. W., Starr, K. R., Dawson, L. A., Price, G. W., Hagan, J. J., Watson, J.> ;Neuropharmacology. 2006 Jun
Join now to see all